121643-47-8 Usage
General Description
2-Chloro-6-methoxypyridine-3-carbonitrile is a chemical compound with the molecular formula C7H5ClN2O. It is a white crystalline powder with the molecular weight of 162.58 g/mol. 2-Chloro-6-methoxypyridine-3-carbonitrile is used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals. It is also used in the production of other organic compounds. 2-Chloro-6-methoxypyridine-3-carbonitrile is considered to be hazardous and should be handled with care, as it can cause irritation to the skin, eyes, and respiratory system. It is important to follow proper safety precautions when handling and storing this chemical.
Check Digit Verification of cas no
The CAS Registry Mumber 121643-47-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,1,6,4 and 3 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 121643-47:
(8*1)+(7*2)+(6*1)+(5*6)+(4*4)+(3*3)+(2*4)+(1*7)=98
98 % 10 = 8
So 121643-47-8 is a valid CAS Registry Number.
121643-47-8Relevant articles and documents
CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS
-
Paragraph 00218, (2019/02/25)
The present disclosure relates to modulators, such as inhibitors, of at least one pathway chosen from USP28 and USP25, pharmaceutical compositions comprising the inhibitors, and methods of using the inhibitors. The modulators, such as inhibitors, of at least one pathway chosen from USP28 and USP25 can be useful in the treatment of cancers, among other ailments.
Neurotrophic factor tyrosine kinase receptor inhibitor
-
Paragraph 0489; 0491-0493, (2018/05/30)
The invention provides a neurotrophic factor tyrosine kinase receptor inhibitor. The tyrosine kinase receptor inhibitor provided by the invention has a tricyclic parent core structure, can inhibit theactivity of Trk kinase and can be used for treating mammalian diseases mediated by the Trk kinase.
Boron-Containing Small Molecules as Anti-Inflammatory Agents
-
Paragraph 0800, (2015/11/16)
Compounds and methods of treating anti-inflammatory conditions are disclosed.
